Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons dr. G.F.H. (Gilles) Diercks

Research interests

Gilles Diercks, born in Lyon (France) in 1969, completed his Medical School at the VUMC, Amsterdam in 1995. He finished his residency in Pathology at the University MedicaI Center of Groningen (UMCG), the Netherlands, in 2009. In that year he became staff member at the Pathology lab in the UMCG with main expertises in dermatopathology, cardiovascular pathology and pathology of soft tissue tumors. He finalized his PhD thesis on “Microalbuminuria. A cardiovascular risk indicator” in 2004 at the Department of Cardiology. His diagnostic activities now cover the whole spectrum of dermatopathology. Dr Diercks’s long term research interests particularly relate to dermatopathology with special attention for immunofluorescence and electron microscopy of the skin. He participates in various national and international collaborative research groups on this subject.

 

Publicaties

Classifying novel DSG1 variants on disease severity in SAM syndrome and palmoplantar keratoderma

Clinical phenotype transition in pemphigus may suggest undertreatment with rituximab: findings from a retrospective single-centre analysis of relapsed patients

Comparative performance of four immunoassays for antilaminin 332 serum IgG in mucous membrane pemphigoid: a multicentre prospective blinded study

Radiotherapy Response Prediction in Myxofibrosarcomas and Undifferentiated Soft Tissue Sarcomas Using DNA Methylation and Copy Number Profiling

Rituximab resistant pemphigus vulgaris successfully treated with obinutuzumab

SOX2 Is a Potential Diagnostic Biomarker and Anticancer Target in Cutaneous Squamous Cell Carcinoma in Dystrophic Epidermolysis Bullosa: A Case Series Study

The tumor microenvironment of cutaneous squamous cell carcinoma in high-risk patient groups: A scoping review

VEXAS syndrome as an underlying cause of disease in patients with Sweet syndrome

Agressieve plaveiselcelcarcinomen bij epidermolysis bullosa

An Unexpected Finding of a PTPN11 Germline Mutation in a Patient With a Melanocytic Lesion With a Somatic MAP2K1 Mutation: Coincidence or Not?

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijn

Meer informatie over de Sustainable Development Goals.